首页> 外文OA文献 >068. 28-JOINT DISEASE ACTIVITY SCORE REMISSION AND IMPROVEMENTS IN SKIN DISEASE OVER 3 YEARS OF TREATMENT WITH APREMILAST: RESULTS FROM THE PALACE 3 STUDY IN DISEASE-MODIFYING ANTI-RHEUMATIC DRUG/BIOLOGIC-EXPERIENCED ACTIVE PSORIATIC ARTHRITIS PATIENTS

【2h】

068. 28-JOINT DISEASE ACTIVITY SCORE REMISSION AND IMPROVEMENTS IN SKIN DISEASE OVER 3 YEARS OF TREATMENT WITH APREMILAST: RESULTS FROM THE PALACE 3 STUDY IN DISEASE-MODIFYING ANTI-RHEUMATIC DRUG/BIOLOGIC-EXPERIENCED ACTIVE PSORIATIC ARTHRITIS PATIENTS

机译：068. 28-关节疾病活动评分缓解和改善皮肤病3年的治疗方法：宫廷3疾病改性抗风湿药物/生物学经验丰富的无活性银屑病关节炎患者的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Christopher J. Edwards; Francisco J. Blanco; Jeffrey Crowley; Melissa McIlraith; Kamal Shah; Lichen Teng; Charles A. Birbara;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Three out of four disease-modifying anti-rheumatic drug-naive rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12months: results from the FIN-ERA cohort [J] . Rannio T., Asikainen J., Hannonen P., Scandinavian journal of rheumatology . 2017,第6期

机译：三种疾病修饰的抗风湿性药物 - 幼稚酸性关节炎患者患者符合28-关节疾病活动评分缓解率为12个月：Fin-ERA Cohort的结果
2. WORK PRODUCTIVITY/INTERFERENCE AND GENERAL HEALTH STATUS IMPROVEMENTS WITH SIRUKUMAB, AN ANTI-IL-6 CYTOKINE MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE TREATMENT WITH DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: RESULTS FROM THE PHASE 3 SIRROUND-D STUDY [J] . Takeuchi T., Karpouzas G., Thorne C., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：西鲁单抗，一种抗IL-6细胞因子单克隆抗体，在患有活动性类风湿关节炎的患者中尽管通过疾病治疗改善了抗风湿性疾病的治疗，但其工作生产率/干扰和总体健康状况得到改善：3
3. Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study) [J] . Lotte Heimans, Gül?ah Akdemir, Kirsten V. C. Wevers-de Boer, Arthritis Research . 2016,第1期

机译：旨在针对早期关节炎患者的无药缓解的疾病活动评分（DAS）-缓解指导的治疗策略的两年结果（IMPROVED研究）
4. Budenofalk~R and non-steroidal anti-inflammatory drugs (NSAIDs) for treatment of anal complications of Crohn's disease with peripheral arthritis in a 15-year-old boy [C] . V. SULYMA, O. SULIMA Falk Symposium . 2002

机译：Budenofalk〜R和非甾体类抗炎药物（NSAIDs）治疗克罗恩病的肛门并发症，在一个15岁的男孩中使用外周关节炎
5. Design, synthesis, biological evaluation and molecular modeling studies of novel multifunctional neuroprotective drugs for the treatment of Parkinson's disease: An effort towards the improvement of in vivo efficacy and modulation of alpha synuclein aggregation property of the neuroprotective parent molecule (d-264) [D] . Modi, Gyan Prakash 2013

机译：用于治疗帕金森氏病的新型多功能神经保护药物的设计，合成，生物学评估和分子模型研究：努力提高神经保护母体分子（d-264）的体内功效和调节α突触核蛋白聚集特性的努力
6. Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study) [O] . Lotte Heimans, Gülşah Akdemir, Kirsten V. C. Wevers-de Boer, 2016

机译：旨在针对早期关节炎患者的无药缓解的疾病活动评分（DAS）-缓解指导的治疗策略的两年结果（IMPROVED研究）
7. Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study) [O] . Lotte Heimans, Gülşah Akdemir, Kirsten V. C. Wevers-de Boer, 2016

机译：旨在针对早期关节炎患者的无药缓解的疾病活动评分（DAS）-缓解指导的治疗策略的两年结果（IMPROVED研究）

068. 28-JOINT DISEASE ACTIVITY SCORE REMISSION AND IMPROVEMENTS IN SKIN DISEASE OVER 3 YEARS OF TREATMENT WITH APREMILAST: RESULTS FROM THE PALACE 3 STUDY IN DISEASE-MODIFYING ANTI-RHEUMATIC DRUG/BIOLOGIC-EXPERIENCED ACTIVE PSORIATIC ARTHRITIS PATIENTS

著录项

引文网络

相似文献

相关主题

期刊订阅